JP2018514208A5 - - Google Patents

Download PDF

Info

Publication number
JP2018514208A5
JP2018514208A5 JP2017555766A JP2017555766A JP2018514208A5 JP 2018514208 A5 JP2018514208 A5 JP 2018514208A5 JP 2017555766 A JP2017555766 A JP 2017555766A JP 2017555766 A JP2017555766 A JP 2017555766A JP 2018514208 A5 JP2018514208 A5 JP 2018514208A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid construct
construct according
signal
intracellular retention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017555766A
Other languages
English (en)
Japanese (ja)
Other versions
JP6836515B2 (ja
JP2018514208A (ja
Filing date
Publication date
Priority claimed from GBGB1507104.6A external-priority patent/GB201507104D0/en
Application filed filed Critical
Publication of JP2018514208A publication Critical patent/JP2018514208A/ja
Publication of JP2018514208A5 publication Critical patent/JP2018514208A5/ja
Application granted granted Critical
Publication of JP6836515B2 publication Critical patent/JP6836515B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017555766A 2015-04-27 2016-04-26 核酸構築物 Active JP6836515B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1507104.6A GB201507104D0 (en) 2015-04-27 2015-04-27 Nucleic acid construct
GB1507104.6 2015-04-27
PCT/GB2016/051164 WO2016174408A1 (en) 2015-04-27 2016-04-26 Nucleic acid construct

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020117039A Division JP2020171313A (ja) 2015-04-27 2020-07-07 核酸構築物

Publications (3)

Publication Number Publication Date
JP2018514208A JP2018514208A (ja) 2018-06-07
JP2018514208A5 true JP2018514208A5 (enExample) 2019-04-11
JP6836515B2 JP6836515B2 (ja) 2021-03-03

Family

ID=53488689

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017555766A Active JP6836515B2 (ja) 2015-04-27 2016-04-26 核酸構築物
JP2020117039A Withdrawn JP2020171313A (ja) 2015-04-27 2020-07-07 核酸構築物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020117039A Withdrawn JP2020171313A (ja) 2015-04-27 2020-07-07 核酸構築物

Country Status (10)

Country Link
US (1) US11530420B2 (enExample)
EP (1) EP3288968B1 (enExample)
JP (2) JP6836515B2 (enExample)
CN (1) CN107532176A (enExample)
AU (1) AU2016254498B2 (enExample)
CA (1) CA2984101A1 (enExample)
ES (1) ES2847698T3 (enExample)
GB (1) GB201507104D0 (enExample)
HK (1) HK1244021A1 (enExample)
WO (1) WO2016174408A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102211120B1 (ko) 2014-05-15 2021-02-03 내셔널 유니버시티 오브 싱가포르 변형된 천연 살해 세포 및 그의 용도
GB201507108D0 (en) 2015-04-27 2015-06-10 Ucl Business Plc Nucleic acid construct
MX2018002744A (es) * 2015-09-04 2018-04-13 Tocagen Inc Vectores recombinantes que comprenden peptido 2a.
US11440958B2 (en) 2016-11-22 2022-09-13 National University Of Singapore Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell malignancies
CN112695050B (zh) * 2017-03-24 2025-08-08 莱蒂恩技术公司 用于用抗cd33免疫疗法治疗癌症的组合物和方法
WO2018182511A1 (en) 2017-03-27 2018-10-04 National University Of Singapore Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
IL269553B2 (en) 2017-03-27 2025-10-01 Nat Univ Singapore Truncated NKG2D chimeric receptors and their uses in immunotherapy with natural killer cells
US11389525B2 (en) 2017-10-27 2022-07-19 Statens Serum Institut Polygene influenza vaccine
CN108359014A (zh) * 2018-02-08 2018-08-03 四川农业大学 含有dhav-1 2a1-p的多肽及其介导的多蛋白共表达方法
CN111801348A (zh) 2018-02-09 2020-10-20 新加坡国立大学 活化性嵌合受体及其在自然杀伤细胞免疫疗法中的用途
SG11202008976YA (en) 2018-04-02 2020-10-29 Nat Univ Singapore Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
GB201805918D0 (en) 2018-04-10 2018-05-23 Autolus Ltd Cell
AU2019326617A1 (en) * 2018-08-24 2021-03-18 Locanabio, Inc. FASL immunomodulatory gene therapy compositions and methods for use
EP3844186A4 (en) 2018-08-29 2022-08-17 National University of Singapore METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
CA3120563A1 (en) 2018-11-26 2020-06-04 Nkarta, Inc. Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
WO2020180882A1 (en) 2019-03-05 2020-09-10 Nkarta, Inc. Cd19-directed chimeric antigen receptors and uses thereof in immunotherapy
GB201914611D0 (en) * 2019-10-09 2019-11-20 Autolus Ltd Engineered immune cell
WO2024197792A1 (en) * 2023-03-31 2024-10-03 Beijing University Of Chinese Medicine A complex comprising a cell penetrating peptide and a copi sorting inhibitor and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998017323A1 (en) * 1996-10-23 1998-04-30 The Trustees Of The University Of Pennsylvania Improved vaccines
EP2468881A3 (en) * 2005-07-21 2012-08-15 Abbott Laboratories Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
CN103483452B (zh) * 2012-06-12 2021-08-13 上海细胞治疗集团有限公司 双信号独立的嵌合抗原受体及其用途
US20160289731A1 (en) * 2012-11-21 2016-10-06 Merz Pharma Gmbh & Co, Kgaa Means and methods for determination of botulinum neurotoxin biological activity
US10934346B2 (en) * 2014-02-14 2021-03-02 Bellicum Pharmaceuticals, Inc. Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule comprising MyD88, CD40 and FKBP12
EP3250536A4 (en) 2015-01-26 2018-11-07 United States Mineral Products Company Corrosion resistant spray applied fire resistive materials

Similar Documents

Publication Publication Date Title
JP2018514209A5 (enExample)
Fujii et al. PA tag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin
JP6836515B2 (ja) 核酸構築物
JP2016533174A5 (enExample)
ZA202006432B (en) T cell receptors
WO2011039508A3 (en) T-cell receptor
JP7704685B2 (ja) 抗原結合タンパク質
IL274547B1 (en) Modified ligand-gated ion channels and methods of use
JP2019521643A5 (enExample)
HRP20220080T1 (hr) Poboljšane imunoglobulinske varijabilne domene koje vežu serumski albumin
Tang et al. Molecular cloning and localization of human syntaxin 16, a member of the syntaxin family of SNARE proteins
FI3527070T3 (fi) Humanisoituja kevytketjuhiiriä
Carrington et al. Sequence and expression of the glycosyl-phosphatidylinositol-specific phospholipase C of Trypanosoma brucei
WO2011112089A3 (en) Mutated rep encoding sequences for use in aav production
JP2019535268A5 (ja) アクチビンIIa型受容体変異体および同変異体を含む医薬組成物
JP2018530315A5 (enExample)
WO2008138649A3 (en) Signaling peptides
WO2020120982A3 (en) Cell
Demirel et al. Tuning the cellular trafficking of the lysosomal peptide transporter TAPL by its N‐terminal domain
Forti et al. Identification of a novel overlapping sequential E epitope (E′) on the bovine leukaemia virus SU glycoprotein and analysis of immunological data
Yant et al. Identification of a cytoplasmic Tyr-XX-Leu motif essential for down regulation of the human cell receptor CD46 in persistent measles virus infection
Nogi et al. Novel affinity tag system using structurally defined antibody‐tag interaction: application to single‐step protein purification
JP2015527074A5 (enExample)
WO2009002939A3 (en) Autophilic antibodies
Jun et al. D‐AKAP 1a is a signal‐anchored protein in the mitochondrial outer membrane